Nurse Practitioner, Family · Boston, MA
NPI
1104600378
Since 2023
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
55 Fruit St
Boston, MA, 02114
Phone (617) 726-1721
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
138 services
Medicare patients, 2024
104
Average age 75
Drug cost, 2024
$2.2M
1,258 prescriptions
Company payments, 2025
$35.73
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelsey Polikowski was code 99215 (office e&m - established), 58 times for 55 patients. In total Kelsey Polikowski billed 138 services in 5 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 58 | 55 | $102.80 | $5,962 |
| 99215 Office E&M - Established | Office | 31 | 22 | $131.84 | $4,087 |
| 99214 Office E&M - Established | Facility | 15 | 15 | $69.12 | $1,037 |
| 99213 Office E&M - Established | Facility | 11 | 11 | $37.89 | $417 |
Medicare prescription drug claims, 2024
In 2024, the drug Kelsey Polikowski prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 118 prescriptions and refills. In total Kelsey Polikowski wrote 1,258 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 118 | 187 | 33 | $117K |
| Ofev Nintedanib Esylate | 115 | 121 | 18 | $1.5M |
| Prednisone Generic | 104 | 140 | 57 | $546 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 94 | 115 | 44 | $3,207 |
| Pirfenidone Generic | 64 | 64 | Under 11 | $295K |
| Incruse Ellipta Umeclidinium Bromide | 60 | 64 | 14 | $22K |
| Ipratropium Bromide Generic | 56 | 98 | 24 | $1,300 |
| Mycophenolate Mofetil Generic | 51 | 93 | 19 | $8,538 |
| Omeprazole Generic | 47 | 119 | 21 | $1,294 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 46 | 56 | 11 | $26K |
| Montelukast Sodium Generic | 44 | 131 | 17 | $742 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 36 | 50 | 13 | $2,474 |
| Advair Hfa Fluticasone Propion/Salmeterol | 32 | 48 | Under 11 | $17K |
| Arnuity Ellipta Fluticasone Furoate | 27 | 33 | 12 | $6,994 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 26 | 36 | Under 11 | $2,301 |
Brand drugs: 677 claims; generic drugs: 581 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelsey Polikowski $35.73 ($35.73 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $35.73.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $35.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.